Form 4: Argan Inc. Executive Receives Stock Options and RSUs
Insider Transaction
Argan Inc. Chief Executive Officer, Charles Edwin Collins IV, was granted stock options and various forms of restricted stock units on April 8, 2026.
Summary
- Charles Edwin Collins IV, Chief Executive Officer of Argan Inc., received a grant of 10-year stock options on April 8, 2026, with an exercise price of $588.28 per share.
- The options are for 332 shares and will vest ratably over three years, starting on April 8, 2027.
- Collins also received Time-Based Restricted Stock Units (TRSUs) for 231 shares, which will vest in equal installments over the next three years, beginning April 8, 2027.
- Additionally, Performance-Based Restricted Stock Units (PRSUs) for a target of 170 shares were granted, subject to the company's Total Stock Return (TSR) performance relative to 12 peer companies over a three-year period.
- The payout for PRSUs can range from 0% to 200% of the target number of shares.
- Earnings Per Share Performance-Based Restricted Stock Units (EPSRSUs) for a target of 2,618 shares were also granted. Vesting depends on the company's cumulative Earnings Per Share (EPS) for fiscal years 2027-2029 compared to a baseline from fiscal years 2024-2026.
- The payout for EPSRSUs can also range from 0% to 200% of the target number of shares.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it details standard executive compensation practices designed to incentivize performance and retention, but does not provide operational or financial results.
Positives
- Grant of stock options and restricted stock units to the CEO indicates a long-term incentive aligned with company performance and shareholder value.
- Performance-based RSUs (PRSUs and EPSRSUs) directly link executive compensation to key company metrics like TSR and EPS growth, aligning executive interests with those of shareholders.
- The multi-year vesting schedule for all equity awards encourages executive retention and long-term commitment to the company.
Negatives
- The high exercise price of $588.28 for stock options suggests a significant increase in share price is required for them to be in-the-money, potentially setting a high bar for executive gain.
- The performance metrics for PRSUs and EPSRSUs are complex and subject to board determination and peer group comparisons, introducing uncertainty in vesting outcomes.
Risks
- The vesting of PRSUs is contingent on Argan Inc.'s Total Stock Return (TSR) ranking against 12 peer companies, which could be impacted by market volatility and industry-specific challenges.
- The vesting of EPSRSUs depends on achieving specific Earnings Per Share (EPS) growth targets over three fiscal years, which could be affected by economic downturns, increased competition, or operational inefficiencies.
- The potential for payouts ranging from 0% to 200% for performance-based awards means that actual compensation could be significantly lower or higher than the target, creating variability.
Future Outlook
The future outlook for Argan Inc. is tied to the performance of its stock price relative to peers (TSR) and its ability to achieve specific Earnings Per Share (EPS) growth targets over the next three fiscal years, as these metrics will determine the vesting of performance-based equity awards granted to the CEO.
Industry Context
StockSavvy.ai notes that the structure of these equity awards, particularly the inclusion of performance-based units tied to TSR and EPS, is a common practice among publicly traded companies to align executive incentives with shareholder interests and drive long-term value creation in the industrial sector.
Stakeholder Impact
- Shareholders: The alignment of executive compensation with TSR and EPS performance is intended to benefit shareholders by driving company growth and increasing stock value.
- Employees: The CEO's equity awards, particularly performance-based ones, may indirectly influence company strategy and resource allocation, potentially impacting employees.
- Management: The awards provide significant potential financial upside for the CEO, contingent on achieving specific performance targets.
Next Steps
- Monitor Argan Inc.'s Total Stock Return (TSR) performance over the next three years relative to its peer group.
- Track Argan Inc.'s Earnings Per Share (EPS) growth for fiscal years ending January 31, 2027, 2028, and 2029.
- Observe the vesting of stock options and restricted stock units on April 8, 2027, and subsequent anniversaries.
- Review Argan Inc.'s 2026 Proxy Statement for disclosure of the peer group used for TSR performance assessment.
Key Dates
| Date | Description |
|---|---|
| 01/31/2024 | Fiscal year end for baseline EPS calculation for EPSRSUs. |
| 01/31/2025 | Fiscal year end for baseline EPS calculation for EPSRSUs. |
| 01/31/2026 | Fiscal year end for baseline EPS calculation for EPSRSUs. |
| 04/08/2026 | Grant date for stock options, TRSUs, PRSUs, and EPSRSUs. |
| 04/08/2027 | First vesting date for stock options and TRSUs. |
| 01/31/2027 | Fiscal year end for EPS calculation for EPSRSUs. |
| 01/31/2028 | Fiscal year end for EPS calculation for EPSRSUs. |
| 01/31/2029 | Fiscal year end for EPS calculation for EPSRSUs. |
| 04/08/2036 | Expiration date for stock options. |
| 04/10/2026 | Date of signature on the Form 4 filing. |
Keywords
Argan Inc., AGX, Form 4, Stock Options, Restricted Stock Units, RSUs, PRSUs, EPSRSUs, Executive Compensation, Insider Trading, SEC Filing, Charles Edwin Collins IV
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.